Stockreport

Rezurock® now reimbursed in Ontario and British Columbia for people living with chronic graft-versus-host disease (GVHD) [Yahoo! Finance]

Sanofi - American Depositary Shares  (SNY) 
US:NYSE Investor Relations: sanofi.com/en/investors
PDF chronic graft-versus-host disease (GVHD) after failure of at least two prior lines of systemic therapy A significant step forward for chronic GVHD patients and their f [Read more]